MedPath

Comparing the Impact of Mindful Interoceptive Mapping and Mindful Breathing on Pain and Opioid Use

Not Applicable
Completed
Conditions
Pain, Chronic
Opioid Use
Interventions
Behavioral: Mindfulness of Breath
Behavioral: Mindful Interoceptive Mapping
Registration Number
NCT04523766
Lead Sponsor
University of Utah
Brief Summary

This is a single site, two-arm, parallel group randomized clinical trial comparing the effect of two mindfulness-based interventions (Mindful Interoceptive Mapping vs. Mindfulness of the Breath) on opioid-treated chronic pain patients' pleasant/unpleasant sensation reports and opioid use.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
149
Inclusion Criteria
  • (1) men/women ≥18 years of age,
  • (2) current chronic low back pain condition determined by physician assessment (e.g., ICD-10 codes M54.5, M54.4, M54.3),
  • (3) reporting pain ≥3 on 0-10 scale with opioid medication, and
  • (4) long-term opioid pharmacotherapy (>3 months of use).
Exclusion Criteria
  • (1) formal mindfulness training (e.g., MBSR/MBRP),
  • (2) current cancer diagnosis,
  • (3) psychosis, suicidality, and moderate/severe substance use disorder in the past year as assessed with the MINI, and
  • (4) unstable illness, as judged by a physician, that may interfere with treatment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mindfulness of BreathMindfulness of Breath-
Mindful Interoceptive MappingMindful Interoceptive Mapping-
Primary Outcome Measures
NameTimeMethod
Immediate Change in Pleasant Sensation RatiosImmediately before and immediately after the final mindfulness training session, approximately 30 minutes

The Multidimensional Assessment of Pleasant and Painful Sensations (MAPPS) is an outline of a human body overlaid by a grid of 786 sensation pixels that was developed using the Qualtrics online survey platform, which can be recreated on any device capable of supporting a web-browser. Mouse clicks allow respondents to identify locations (i.e., grid pixels) on the manikin where they feel both pleasant and unpleasant sensations. Clicking once in any grid pixel turns that location blue, indicating a pleasant sensation. Clicking twice in any grid pixel turns that location red, indicating an unpleasant sensation. A ratio of pleasant to unpleasant sensations is derived from MAPPS.

Longer-Term Change in Pleasant Sensation RatiosAt baseline and posttreatment, approximately 1.5 months

The Multidimensional Assessment of Pleasant and Painful Sensations (MAPPS) is an outline of a human body overlaid by a grid of 786 sensation pixels that was developed using the Qualtrics online survey platform, which can be recreated on any device capable of supporting a web-browser. Mouse clicks allow respondents to identify locations (i.e., grid pixels) on the manikin where they feel both pleasant and unpleasant sensations. Clicking once in any grid pixel turns that location blue, indicating a pleasant sensation. Clicking twice in any grid pixel turns that location red, indicating an unpleasant sensation. A ratio of pleasant to unpleasant sensations is derived from MAPPS.

Secondary Outcome Measures
NameTimeMethod
Change in Opioid Medication DesireImmediately before and immediately after the final mindfulness training session, approximately 30 minutes

Single-item Numeric Rating Scale (0-10), with 0 indicating no desire for opioid medication and 10 representing the an intense desire for opioid medication.

Change in Pain Functional InterferenceAt pretreatment and 1-month follow-up, approximately 3 months

Pain functional interference will be assessed with the Brief Pain Inventory.

Change in Pain IntensityImmediately before and immediately after the final mindfulness training session, approximately 30 minutes

Single-item Numeric Rating Scale (0-10), with 0 indicating no pain and 10 representing the an most intense pain imaginable.

Change in Opioid UseAt baseline and 1-month follow-up, approximately 3 months

Opioid Use will be assessed with a timeline follow-back procedure.

Trial Locations

Locations (1)

University of Utah

🇺🇸

Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath